Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease

Background: Early identification of individuals at a high risk of cardiovascular disease (CVD) is crucial. This study aimed to construct a nomogram for CVD risk prediction in the general population. Methods: This retrospective study analyzed the data between January 2012 and September 2020 at the Ph...

Full description

Bibliographic Details
Main Authors: Xuechun Shen, Wei He, Jinyu Sun, Zuhong Zhang, Qiushuang Li, Haiyan Zhang, Mingzhi Long
Format: Article
Language:English
Published: IMR Press 2023-01-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/24/2/10.31083/j.rcm2402035
_version_ 1828002985178824704
author Xuechun Shen
Wei He
Jinyu Sun
Zuhong Zhang
Qiushuang Li
Haiyan Zhang
Mingzhi Long
author_facet Xuechun Shen
Wei He
Jinyu Sun
Zuhong Zhang
Qiushuang Li
Haiyan Zhang
Mingzhi Long
author_sort Xuechun Shen
collection DOAJ
description Background: Early identification of individuals at a high risk of cardiovascular disease (CVD) is crucial. This study aimed to construct a nomogram for CVD risk prediction in the general population. Methods: This retrospective study analyzed the data between January 2012 and September 2020 at the Physical Examination Center of the Second Affiliated Hospital of Nanjing Medical University (randomized 7:3 to the training and validation cohorts). The outcome was the occurrence of CVD events, which were defined as sudden cardiac death or any death related to myocardial infarction, acute exacerbation of heart failure, or stroke. The least absolute shrinkage and selection operator (LASSO) method and multivariate logistic regression were applied to screen the significant variables related to CVD. Results: Among the 537 patients, 54 had CVD (10.1%). The median cardiac myosin-binding protein-C (cMyBP-C) level in the CVD group was higher than in the no-CVD group (42.25 pg/mL VS 25.00 pg/mL, p = 0.001). After LASSO selection and multivariable analysis, cMyBP-C (Odds ratio [OR] = 1.004, 95% CI [CI, confidence interval]: 1.000–1.008, p = 0.035), age (OR = 1.023, 95% CI: 0.999–1.048, p = 0.062), diastolic blood pressure (OR = 1.025, 95% CI: 0.995–1.058, p = 0.103), cigarettes per day (OR = 1.066, 95% CI: 1.021–1.113, p = 0.003), and family history of CVD (OR = 2.219, 95% CI: 1.003–4.893, p = 0.047) were associated with future CVD events (p < 0.200). The model, including cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD, displayed a high predictive ability with an area under the curve (AUC) of 0.816 (95% CI: 0.714–0.918) in the training cohort (specificity and negative predictive value of 0.92 and 0.96) and 0.774 (95% CI: 0.703–0.845) in the validation cohort. Conclusions: A nomogram based on cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD was constructed. The model displayed a high predictive ability.
first_indexed 2024-04-10T06:52:01Z
format Article
id doaj.art-a7517c99a4ad4020a4ff88d891bc0ade
institution Directory Open Access Journal
issn 1530-6550
language English
last_indexed 2024-04-10T06:52:01Z
publishDate 2023-01-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj.art-a7517c99a4ad4020a4ff88d891bc0ade2023-02-28T08:09:00ZengIMR PressReviews in Cardiovascular Medicine1530-65502023-01-012423510.31083/j.rcm2402035S1530-6550(22)00782-7Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular DiseaseXuechun Shen0Wei He1Jinyu Sun2Zuhong Zhang3Qiushuang Li4Haiyan Zhang5Mingzhi Long6Department of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, 210011 Nanjing, Jiangsu, ChinaDepartment of Geriatrics, The Second Affiliated Hospital of Nanjing Medical University, 210011 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, 210011 Nanjing, Jiangsu, ChinaDepartment of Technology, Nanjing Bottests Biotechnology Co, Ltd, 211112 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, 210011 Nanjing, Jiangsu, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, 210011 Nanjing, Jiangsu, ChinaBackground: Early identification of individuals at a high risk of cardiovascular disease (CVD) is crucial. This study aimed to construct a nomogram for CVD risk prediction in the general population. Methods: This retrospective study analyzed the data between January 2012 and September 2020 at the Physical Examination Center of the Second Affiliated Hospital of Nanjing Medical University (randomized 7:3 to the training and validation cohorts). The outcome was the occurrence of CVD events, which were defined as sudden cardiac death or any death related to myocardial infarction, acute exacerbation of heart failure, or stroke. The least absolute shrinkage and selection operator (LASSO) method and multivariate logistic regression were applied to screen the significant variables related to CVD. Results: Among the 537 patients, 54 had CVD (10.1%). The median cardiac myosin-binding protein-C (cMyBP-C) level in the CVD group was higher than in the no-CVD group (42.25 pg/mL VS 25.00 pg/mL, p = 0.001). After LASSO selection and multivariable analysis, cMyBP-C (Odds ratio [OR] = 1.004, 95% CI [CI, confidence interval]: 1.000–1.008, p = 0.035), age (OR = 1.023, 95% CI: 0.999–1.048, p = 0.062), diastolic blood pressure (OR = 1.025, 95% CI: 0.995–1.058, p = 0.103), cigarettes per day (OR = 1.066, 95% CI: 1.021–1.113, p = 0.003), and family history of CVD (OR = 2.219, 95% CI: 1.003–4.893, p = 0.047) were associated with future CVD events (p < 0.200). The model, including cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD, displayed a high predictive ability with an area under the curve (AUC) of 0.816 (95% CI: 0.714–0.918) in the training cohort (specificity and negative predictive value of 0.92 and 0.96) and 0.774 (95% CI: 0.703–0.845) in the validation cohort. Conclusions: A nomogram based on cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD was constructed. The model displayed a high predictive ability.https://www.imrpress.com/journal/RCM/24/2/10.31083/j.rcm2402035biomarkercardiac myosin-binding protein-ccardiovascular diseasenomogramrisk prediction
spellingShingle Xuechun Shen
Wei He
Jinyu Sun
Zuhong Zhang
Qiushuang Li
Haiyan Zhang
Mingzhi Long
Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease
Reviews in Cardiovascular Medicine
biomarker
cardiac myosin-binding protein-c
cardiovascular disease
nomogram
risk prediction
title Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease
title_full Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease
title_fullStr Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease
title_full_unstemmed Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease
title_short Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease
title_sort development and validation of a nomogram to predict the future risk of cardiovascular disease
topic biomarker
cardiac myosin-binding protein-c
cardiovascular disease
nomogram
risk prediction
url https://www.imrpress.com/journal/RCM/24/2/10.31083/j.rcm2402035
work_keys_str_mv AT xuechunshen developmentandvalidationofanomogramtopredictthefutureriskofcardiovasculardisease
AT weihe developmentandvalidationofanomogramtopredictthefutureriskofcardiovasculardisease
AT jinyusun developmentandvalidationofanomogramtopredictthefutureriskofcardiovasculardisease
AT zuhongzhang developmentandvalidationofanomogramtopredictthefutureriskofcardiovasculardisease
AT qiushuangli developmentandvalidationofanomogramtopredictthefutureriskofcardiovasculardisease
AT haiyanzhang developmentandvalidationofanomogramtopredictthefutureriskofcardiovasculardisease
AT mingzhilong developmentandvalidationofanomogramtopredictthefutureriskofcardiovasculardisease